Abstract
Objective: Adult Comorbidity Evaluation 27 (ACE-27) is a validated tool that reflects the number and severity of medical comorbidity. ACE-27 is an independent prognostic factor for endometrial cancer (EC) patients after adjusting for stage, grade, histology, and adjuvant therapy. Our objective was to evaluate the impact of ACE-27 score on disease-specific survival (DSS) and overall survival (OS) in stage I EC patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
